2020 Q3 Form 10-Q Financial Statement

#000155837020009787 Filed on August 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $98.14M $86.47M $74.36M
YoY Change 25.97% 16.3% 17.89%
Cost Of Revenue $51.80M $42.73M $41.38M
YoY Change 18.0% 3.26% 0.93%
Gross Profit $46.30M $43.74M $30.53M
YoY Change 36.06% 43.27% 38.31%
Gross Profit Margin 47.18% 50.58% 41.06%
Selling, General & Admin $75.68M $68.19M $47.04M
YoY Change 33.44% 44.95% 25.78%
% of Gross Profit 163.45% 155.89% 154.08%
Research & Development $26.42M $23.01M $12.12M
YoY Change 106.48% 89.75% 1.88%
% of Gross Profit 57.06% 52.59% 39.71%
Depreciation & Amortization $2.180M $2.210M $3.952M
YoY Change -63.18% -44.08% 117.14%
% of Gross Profit 4.71% 5.05% 12.94%
Operating Expenses $102.1M $91.19M $59.17M
YoY Change 46.88% 54.13% 20.01%
Operating Profit -$55.78M -$51.66M -$28.64M
YoY Change 164.42% 80.4% 5.18%
Interest Expense $4.270M $4.038M $2.721M
YoY Change 59.81% 48.4% -204.65%
% of Operating Profit
Other Income/Expense, Net $1.700M $1.900M $800.0K
YoY Change 142.86% 137.5% -120.51%
Pretax Income -$58.30M -$59.62M -$30.52M
YoY Change 152.45% 95.35% -9.43%
Income Tax $25.00K $15.00K $1.900M
% Of Pretax Income
Net Earnings -$58.32M -$59.64M -$32.42M
YoY Change 152.08% 83.97% -4.16%
Net Earnings / Revenue -59.43% -68.97% -43.6%
Basic Earnings Per Share -$0.48
Diluted Earnings Per Share -$720.6K -$753.5K -$0.48
COMMON SHARES
Basic Shares Outstanding 79.89M 78.73M 68.22M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $809.6M $571.2M $238.0M
YoY Change 239.74% 140.0% 186.06%
Cash & Equivalents $209.4M $77.32M $29.98M
Short-Term Investments $600.2M $493.9M $208.1M
Other Short-Term Assets $15.40M $15.60M $5.800M
YoY Change 9.22% 168.97% -54.69%
Inventory $20.38M $18.03M $15.20M
Prepaid Expenses
Receivables $70.67M $58.71M $63.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $916.0M $663.5M $322.0M
YoY Change 182.98% 106.06% 94.68%
LONG-TERM ASSETS
Property, Plant & Equipment $28.25M $25.93M $48.30M
YoY Change -35.5% -46.33% 90.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.16M $12.36M $13.10M
YoY Change -4.28% -5.67% 254.05%
Total Long-Term Assets $60.70M $59.76M $61.30M
YoY Change 7.25% -2.52% 111.38%
TOTAL ASSETS
Total Short-Term Assets $916.0M $663.5M $322.0M
Total Long-Term Assets $60.70M $59.76M $61.30M
Total Assets $976.7M $723.3M $383.3M
YoY Change 156.83% 88.69% 97.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.250M $3.450M $8.300M
YoY Change 0.54% -58.43% 7.79%
Accrued Expenses $62.89M $53.08M $38.40M
YoY Change 42.29% 38.23% 24.68%
Deferred Revenue $51.23M $52.39M
YoY Change
Short-Term Debt $50.10M $50.10M $50.10M
YoY Change 0.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $195.9M $175.6M $126.9M
YoY Change 41.94% 38.35% 29.36%
LONG-TERM LIABILITIES
Long-Term Debt $200.0M $197.5M $73.50M
YoY Change 171.74% 168.71% 0.41%
Other Long-Term Liabilities $310.0K $310.0K $89.80M
YoY Change -99.63% -99.65% 99.11%
Total Long-Term Liabilities $310.0K $310.0K $163.3M
YoY Change -99.8% -99.81% 38.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $195.9M $175.6M $126.9M
Total Long-Term Liabilities $310.0K $310.0K $163.3M
Total Liabilities $440.7M $419.0M $290.2M
YoY Change 49.09% 44.38% 34.1%
SHAREHOLDERS EQUITY
Retained Earnings -$852.9M -$794.6M
YoY Change
Common Stock $1.384B $1.093B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $536.0M $304.3M $93.09M
YoY Change
Total Liabilities & Shareholders Equity $976.7M $723.3M $383.3M
YoY Change 156.83% 88.69% 97.17%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$58.32M -$59.64M -$32.42M
YoY Change 152.08% 83.97% -4.16%
Depreciation, Depletion And Amortization $2.180M $2.210M $3.952M
YoY Change -63.18% -44.08% 117.14%
Cash From Operating Activities -$33.13M -$40.98M -$35.75M
YoY Change -31.54% 14.63% 0.57%
INVESTING ACTIVITIES
Capital Expenditures -$1.940M -$2.210M $1.599M
YoY Change -175.96% -238.21% -520.79%
Acquisitions
YoY Change
Other Investing Activities -$108.4M -$163.2M -$113.3M
YoY Change -451.38% 44.11% -1358.56%
Cash From Investing Activities -$110.4M -$165.4M -$101.0M
YoY Change 55.19% 63.81% -1271.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $271.0M $108.1M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 275.6M 209.6M 115.7M
YoY Change 129.38% 81.12% 2011.77%
NET CHANGE
Cash From Operating Activities -33.13M -40.98M -35.75M
Cash From Investing Activities -110.4M -165.4M -101.0M
Cash From Financing Activities 275.6M 209.6M 115.7M
Net Change In Cash 132.1M 3.180M -21.02M
YoY Change 19921.21% -115.13% -2.0%
FREE CASH FLOW
Cash From Operating Activities -$33.13M -$40.98M -$35.75M
Capital Expenditures -$1.940M -$2.210M $1.599M
Free Cash Flow -$31.19M -$38.77M -$37.35M
YoY Change -38.78% 3.8% 6.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
55000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4850000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1347000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3849000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Operating Lease Cost
OperatingLeaseCost
3880000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79717000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78005000
dei Entity Registrant Name
EntityRegistrantName
Natera, Inc.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001604821
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Address Country
EntityAddressCountry
US
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-37478
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0894487
dei Entity Address Address Line1
EntityAddressAddressLine1
201 Industrial Road, Suite 410
dei Entity Address City Or Town
EntityAddressCityOrTown
San Carlos
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94070
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
249-9090
dei Security12g Title
Security12gTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
NTRA
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79887822
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77322000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61926000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
55000
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
493852000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
379065000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3080000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2919000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
58706000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53351000
CY2020Q2 us-gaap Inventory Net
InventoryNet
18033000
CY2019Q4 us-gaap Inventory Net
InventoryNet
12394000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15536000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16376000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
663504000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
523167000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25925000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23283000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21475000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23730000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12357000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12476000
CY2020Q2 us-gaap Assets
Assets
723261000
CY2019Q4 us-gaap Assets
Assets
582656000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3450000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8604000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16583000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16088000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53082000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49043000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
52392000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56016000
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
50053000
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
50123000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
175560000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
179874000
CY2020Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
197476000
CY2019Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
73656000
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22533000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23808000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23115000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26297000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
310000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
310000
CY2020Q2 us-gaap Liabilities
Liabilities
418994000
CY2019Q4 us-gaap Liabilities
Liabilities
303945000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79717000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78005000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
8000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1093072000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
976955000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-794583000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-699171000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5770000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
919000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
304267000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
278711000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
723261000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
582656000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86472000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74355000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
180484000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141179000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42731000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41382000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
84251000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1061000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
82987000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23005000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12124000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41230000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23559000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68188000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47042000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
133869000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
90874000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
138132000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
102991000
us-gaap Costs And Expenses
CostsAndExpenses
267016000
us-gaap Costs And Expenses
CostsAndExpenses
201561000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-51660000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28636000
us-gaap Operating Income Loss
OperatingIncomeLoss
-86532000
us-gaap Operating Income Loss
OperatingIncomeLoss
-60382000
CY2020Q2 us-gaap Interest Expense
InterestExpense
4038000
CY2019Q2 us-gaap Interest Expense
InterestExpense
2721000
us-gaap Interest Expense
InterestExpense
6502000
us-gaap Interest Expense
InterestExpense
5445000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1924000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
836000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3911000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1289000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59622000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30521000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94971000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-64538000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1895000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1969000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-59637000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-32416000
us-gaap Net Income Loss
NetIncomeLoss
-95009000
us-gaap Net Income Loss
NetIncomeLoss
-66507000
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
104000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59533000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31355000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-90159000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65160000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79069000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68224000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78681000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65542000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
4986000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3405000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2147000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
107595000
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
506000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5804000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1061000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-32416000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
93088000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
32162000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5983000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2147000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
107595000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
506000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9855000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1347000
us-gaap Net Income Loss
NetIncomeLoss
-66507000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
93088000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
258927000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6981000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3062000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
82873000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11957000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
104000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-59637000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
304267000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
278711000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10808000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3062000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
82873000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19374000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4851000
ntra Cumulative Effect Of New Accounting Principle In Period Of Adoption Duration
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionDuration
-403000
us-gaap Net Income Loss
NetIncomeLoss
-95009000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
304267000
us-gaap Profit Loss
ProfitLoss
-95009000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-66507000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4036000
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3952000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1887000
CY2019Q2 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
151000
us-gaap Share Based Compensation
ShareBasedCompensation
19374000
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
9855000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2180000
CY2019Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
162176000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
11500000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
142815000
CY2019Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
62780000
CY2019Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
215000
us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
341000
CY2019Q2 us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
415000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10130000
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1599000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121954000
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100995000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10808000
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5983000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1445000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5972000
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
829000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5410000
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1815000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5610000
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4464000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-99000
CY2019Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9499000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4684000
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6378000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
495000
CY2019Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2519000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
6602000
CY2019Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2331000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4900000
CY2019Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
35492000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76080000
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35751000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
266139000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
3062000
CY2019Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2147000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
278317000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
78757000
CY2019Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
107595000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
213430000
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
115725000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
15396000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-21021000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61981000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51004000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77377000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29983000
us-gaap Interest Paid Net
InterestPaidNet
2976000
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
7343000
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
28191000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
255000
CY2019Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
323000
CY2019Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1691000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Net Income Loss
NetIncomeLoss
-95000000.0
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-794600000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77400000
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
493900000
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
50100000
CY2019Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
600000
CY2019Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
108100000
CY2019Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
400000
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
216200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:40.3pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with generally accepted accounting principles (GAAP) in the United States requires management to make estimates and assumptions about future events that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Significant items subject to such estimates include the allowance for doubtful accounts, the operating right-of-use assets and the associated lease liabilities, deferred revenues associated with unsatisfied performance obligations, accrued liability for potential refund requests, the valuation of the Convertible Notes,  stock-based compensation, the fair value of common stock, income tax uncertainties, and the expected consideration to be received from contracts with customers. These estimates and assumptions are based on management's best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors, including contractual terms and statutory limits; however, actual results could differ from these estimates and could have an adverse effect on the Company's financial statements.</p>
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2919000
CY2020Q2 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
403000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1445000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
457000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4310000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 10pt 0pt;">Investments consist primarily of debt securities such as U.S. Treasuries, U.S. agency and municipal bonds. Management determines the appropriate classification of securities at the time of purchase and re-evaluates such determination at each balance sheet date. The Company generally classifies its entire investment portfolio as available-for-sale. The Company views its available-for-sale portfolio as available for use in current operations. Accordingly, the Company classifies all investments as short-term, irrespective of maturity date. Available-for-sale securities are carried at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), which is a separate component of stockholders’ equity.</p>
CY2020Q2 ntra Increase Decrease Accumulated Other Comprehensive Income Loss
IncreaseDecreaseAccumulatedOtherComprehensiveIncomeLoss
104000
CY2019Q2 ntra Increase Decrease Accumulated Other Comprehensive Income Loss
IncreaseDecreaseAccumulatedOtherComprehensiveIncomeLoss
1061000
ntra Increase Decrease Accumulated Other Comprehensive Income Loss
IncreaseDecreaseAccumulatedOtherComprehensiveIncomeLoss
4850000
ntra Increase Decrease Accumulated Other Comprehensive Income Loss
IncreaseDecreaseAccumulatedOtherComprehensiveIncomeLoss
1347000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86472000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74355000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
180484000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141179000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86472000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74355000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
180484000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141179000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
58706000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53351000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
52392000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56016000
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22533000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23808000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
74925000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
79824000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
79824000
ntra Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
746000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-4943000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-702000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
74925000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-4900000
ntra Number Of Investments Sold
NumberOfInvestmentsSold
11500000
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
9
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
264713000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
265534000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
223369000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
228318000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
488082000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
493852000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71410000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64807000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45485000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41524000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25925000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23283000
us-gaap Depreciation
Depreciation
4000000.0
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2098000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1850000
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7154000
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5767000
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4179000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5710000
CY2020Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
3152000
CY2019Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
2761000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16583000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16088000
CY2020Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
13100000
CY2019Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
9410000
CY2020Q2 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
6189000
CY2019Q4 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
8408000
CY2020Q2 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
5823000
CY2019Q4 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
4301000
CY2020Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2558000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2957000
CY2020Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4596000
CY2019Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
2873000
CY2020Q2 ntra Accrued Shipping Charges
AccruedShippingCharges
658000
CY2019Q4 ntra Accrued Shipping Charges
AccruedShippingCharges
305000
CY2020Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1142000
CY2020Q2 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
2667000
CY2020Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
13100000
CY2019Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
10897000
CY2019Q4 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
2269000
CY2020Q2 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
2269000
CY2019Q4 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
1092000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6160000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5739000
CY2020Q2 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
233000
CY2019Q4 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
1482000
CY2020Q2 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
7687000
CY2019Q4 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
8516000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53082000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49043000
CY2019Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
9410000
CY2018Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
10012000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
8563000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
4799000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
4873000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
3914000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1622000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1263000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6160000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23115000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
29275000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M19D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1077
CY2020Q2 us-gaap Lease Cost
LeaseCost
1900000
us-gaap Lease Cost
LeaseCost
3900000
CY2019Q2 us-gaap Lease Cost
LeaseCost
2000000.0
us-gaap Lease Cost
LeaseCost
3800000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2200000
us-gaap Operating Lease Payments
OperatingLeasePayments
4400000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4439000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9067000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9319000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7797000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2400000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4730000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
37752000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8477000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
29275000
CY2020Q2 us-gaap Purchase Obligation
PurchaseObligation
36228000
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
25000
us-gaap Repayments Of Debt
RepaymentsOfDebt
79200000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
75000000.0
CY2020Q2 ntra Debt Early Payment Penalties
DebtEarlyPaymentPenalties
3800000
us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
400000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
ntra Schedule Of Interest Expense Table Text Blcok
ScheduleOfInterestExpenseTableTextBlcok
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;line-height:1.19;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:80.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:19.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:19.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:19.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><i style="font-style:italic;">(in thousands)</i></p></td></tr><tr><td style="vertical-align:bottom;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Cash interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 12pt;">Contractual interest expense</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,348</p></td></tr><tr><td style="vertical-align:bottom;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Non-cash interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 12pt;">Amortization of debt discount and debt issuance cost</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:15.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,030</p></td></tr><tr><td style="vertical-align:bottom;width:80.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 24pt;">Total interest expense</p></td><td style="vertical-align:bottom;width:3.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,378</p></td></tr></table>
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000.0
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2020Q2 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9300000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8600000
CY2020Q2 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-59637000
CY2019Q2 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-32416000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-95009000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-66507000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79069000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68224000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78681000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65542000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19335000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11791000

Files In Submission

Name View Source Status
0001558370-20-009787-index-headers.html Edgar Link pending
0001558370-20-009787-index.html Edgar Link pending
0001558370-20-009787.txt Edgar Link pending
0001558370-20-009787-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntra-20200630.xsd Edgar Link pending
ntra-20200630x10q.htm Edgar Link pending
ntra-20200630x10q_htm.xml Edgar Link completed
ntra-20200630xex10d1.htm Edgar Link pending
ntra-20200630xex31d1.htm Edgar Link pending
ntra-20200630xex31d2.htm Edgar Link pending
ntra-20200630xex32d1.htm Edgar Link pending
ntra-20200630xex32d2.htm Edgar Link pending
ntra-20200630_cal.xml Edgar Link unprocessable
ntra-20200630_def.xml Edgar Link unprocessable
ntra-20200630_lab.xml Edgar Link unprocessable
ntra-20200630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending